SC-51089 hydrate

• Catalog No.: PZ0138
• M. F.: C22H22Cl2N4O4
• M. W.: 477.34048
• Purity: ≥98% (HPLC)

SYNONYMS

• IUPAC name: N'-{6-chloro-2-oxa-9-azatricyclo[9.4.0.0^3,^8]pentadeca-1(15),3,5,7,11,13-hexaene-9-carbonyl}-3-(pyridin-4-yl)propanehydrazide hydrate hydrochloride
• IUPAC Traditional name: N'-{6-chloro-2-oxa-9-azatricyclo[9.4.0.0^3,^8]pentadeca-1(15),3,5,7,11,13-hexaene-9-carbonyl}-3-(pyridin-4-yl)propanehydrazide hydrate hydrochloride
• Synonyms: 8-Chloro-dibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid 2-[1-oxo-3-(4-pyridinyl)propyl]hydrazide monohydrochloride hydrate

DATABASE IDS

• MDL Number: MFCD17215974

PROPERTIES

• Empirical Formula (Hill Notation): C22H19ClN4O3·HCl · xH2O
• Purity: ≥98% (HPLC)
• Apperance: white to off-white powder
• Solubility: DMSO: ≥10 mg/mL
• GHS Signal Word: Danger
• GHS Hazard statements: H301-H315-H319-H335
• European Hazard Symbols: Toxic (T)
• GHS Precautionary statements: P261-P301 + P310-P305 + P351 + P338
• RID/ADR: UN 2811 6.1/PG 3
• Risk Statements: 25-36/37/38
• Safety Statements: 26-45
• Storage Temperature: room temp
• Hazard Class: 6.1
• UN Number: 2811
• Packing Group: 3
• German water hazard class: 3

DETAILS

Description (English)

Biochem/physiol Actions
SC-51089 is a selective EP1 prostanoid receptor antagonist.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.

Description (简体中文)

Biochem/physiol Actions
SC-51089 is a selective EP1 prostanoid receptor antagonist.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.